Related Experiment Video
Updated: Jul 15, 2026
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth
Yu-Ching Lin1, Liang You, Zhidong Xu
1Thoracic Oncology Laboratory, Department of Surgery, University of California, San Francisco, San Francisco, CA 94115, USA.
Abstract:
Silencing of Wnt antagonists with aberrant activation of Wnt signaling is a common phenomenon in various human cancers. Wnt inhibitory factor-1 (WIF-1) is a secreted antagonist of Wnt signaling and acts through direct binding to Wnt in the extracellular space. In this study, we tried to illuminate the impact of WIF-1 gene expression in melanoma with WIF-1 silencing by in vitro and in vivo studies. We restored the expression of WIF-1 by nonviral gene transfer with a pcDNA3.1 vector. We demonstrated inhibition of melanoma cell growth after WIF-1 restoration in colony formation and proliferation assays in vitro. In addition, the inhibitory effect was related to downregulation of Wnt signaling, which was demonstrated at both the transcriptional and translational levels. Furthermore, by using a xenograft mouse model, we confirmed the effect of WIF-1 expression in suppressing tumor growth by inhibition of Wnt signaling in vivo. Our results suggest the potential for further application of WIF-1 gene therapy in melanoma with WIF-1 silencing.
Insights
Restoring Wnt inhibitory factor-1 (WIF-1) gene expression suppressed melanoma cell growth and tumor progression. This WIF-1 gene therapy approach inhibited Wnt signaling, offering potential for melanoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Aberrant Wnt signaling activation, due to Wnt antagonist silencing, is prevalent in human cancers.
- Wnt inhibitory factor-1 (WIF-1) is a secreted Wnt antagonist that binds Wnt ligands extracellularly.
- WIF-1 silencing is observed in melanoma, contributing to aberrant Wnt pathway activation.
Purpose of the Study:
- To investigate the impact of restoring WIF-1 gene expression in melanoma.
- To evaluate the therapeutic potential of WIF-1 gene restoration in preclinical melanoma models.
Main Methods:
- Nonviral gene transfer using a pcDNA3.1 vector to restore WIF-1 expression.
- In vitro studies including colony formation and proliferation assays.
- In vivo studies utilizing a xenograft mouse model.
- Analysis of Wnt signaling at transcriptional and translational levels.
Main Results:
- Restored WIF-1 expression inhibited melanoma cell growth in vitro.
- WIF-1 restoration led to downregulation of Wnt signaling components.
- In vivo studies confirmed WIF-1 expression suppressed tumor growth in a xenograft model.
- Inhibition of tumor growth correlated with suppressed Wnt signaling.
Conclusions:
- WIF-1 gene restoration effectively suppresses melanoma cell proliferation and tumor growth.
- The mechanism involves the inhibition of the Wnt signaling pathway.
- WIF-1 gene therapy presents a promising therapeutic strategy for melanoma with WIF-1 silencing.
